Complement and neutrophil function changes after liver resection in humans

World Journal of Surgery

Volumn 33, Issue 12, 2009, Pages 2635-2643

  Strey, Christoph Werner ^a   Siegmund, Britta ^a   Rosenblum, Saskia ^a   Marquez Pinilla, Rosa Maria ^a   Oppermann, Elsie ^a   Huber Lang, Markus ^b   Lambris, John D ^c   Bechstein, Wolf O ^a  

^a GOETHE UNIVERSITY   (Germany)

^b UNIVERSITY OF ULM MEDICAL SCHOOL   (Germany)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANAPHYLATOXIN; COMPLEMENT;

ADULT; AGED; ANIMAL; ARTICLE; HUMAN; IMMUNOLOGY; LIVER; LIVER REGENERATION; LIVER RESECTION; MALE; MIDDLE AGED; MONOCYTE; MOUSE; NEUTROPHIL;

ADULT; AGED; AGED, 80 AND OVER; ANAPHYLATOXINS; ANIMALS; COMPLEMENT SYSTEM PROTEINS; HEPATECTOMY; HUMANS; LIVER; LIVER REGENERATION; MALE; MICE; MIDDLE AGED; MONOCYTES; NEUTROPHILS;

EID: 77956076815     PISSN: 03642313     EISSN: 14322323     Source Type: Journal    
DOI: 10.1007/s00268-009-0209-x     Document Type: Article

References (18)

1. Mastellos D, Morikis D, Strey C et al (2004) From atoms to systems: a cross-disciplinary approach to complement-mediated functions. Mol Immunol 41:153-164
2. Strey CW, Markiewski M, Mastellos D et al (2003) The proinflammatory mediators C3a and C5a are essential for liver regeneration. J Exp Med 198:913-923
3. Markiewski MM, DeAngelis RA, Lambris JD (2006) Liver inflammation and regeneration: two distinct biological phenomena or parallel pathophysiologic processes? Mol Immunol 43:45-56
4. Clark A, Weymann A, Hartman E et al (2008) Evidence for nontraditional activation of complement factor C3 during murine liver regeneration. Mol Immunol 45:3125-3132
5. Markiewski MM, DeAngelis RA, Strey CW et al (2009) The regulation of liver cell survival by complement. J Immunol 182:5412-5418
6. Huber-Lang M, Sarma JV, Rittirsch D et al (2005) Changes in the novel orphan, C5a receptor (C5L2), during experimental sepsis and sepsis in humans. J Immunol 174:1104-1110
7. Matsuda N, Hattori Y (2006) Systemic inflammatory response syndrome (SIRS): molecular pathophysiology and gene therapy. J Pharmacol Sci 101:189-198
8. Borregaard N, Kjeldsen L, Sengelov H et al (1994) Changes in subcellular localization and surface expression of L-selectin, alkaline phosphatase, and Mac-1 in human neutrophils during stimulation with inflammatory mediators. J Leukoc Biol 56:80-87
9. Marc MM, Korosec P, Kosnik M et al (2004) Complement factors c3a, c4a, and c5a in chronic obstructive pulmonary disease and asthma. Am J Respir Cell Mol Biol 31:216-219
10. March DR, Proctor LM, Stoermer MJ et al (2004) Potent cyclic antagonists of the complement C5a receptor on human polymorphonuclear leukocytes. Relationships between structures and activity. Mol Pharmacol 65:868-879
11. Monari C, Kozel TR, Bistoni F et al (2002) Modulation of C5aR expression on human neutrophils by encapsulated and acapsular Cryptococcus neoformans. Infect Immunol 70:3363-3370
12. Huber-Lang M, Sarma JV, Zetoune FS et al (2006) Generation of C5a in the absence of C3: a new complement activation pathway. Nat Med 12:682-687
13. Markiewski MM, Nilsson B, Nilsson EK et al (2007) Complement and coagulation: strangers or partners in crime? Trends Immunol 28:184-192
14. Geissmann F, Jung S, Littman DR (2003) Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity 19:71-82
15. Hume DA (2008) Differentiation and heterogeneity in the mononuclear phagocyte system. Mucosal Immunol 1:432-441
16. Montalvo-Jave EE, Escalante-Tattersfield T, Ortega-Salgado JA et al (2008) Factors in the pathophysiology of the liver ischemia- reperfusion injury. J Surg Res 147:153-159
17. Higginbottom A, Cain SA, Woodruff TM et al (2005) Comparative agonist/antagonist responses in mutant human C5a receptors define the ligand binding site. J Biol Chem 280:17831-17840
18. Chen NJ, Mirtsos C, Suh D et al (2007) C5L2 is critical for the biological activities of the anaphylatoxins C5a and C3a. Nature 446:203-207